FDA Proposal to Remove Adequate Provision Rules Could End Pharma TV Advertising

By Campaign US · Campaign US · 2026-07-20

Campaign US reports that the FDA is moving to eliminate the 1997 guidance allowing simplified risk disclosures in broadcast media. This shift would require pharmaceutical brands to include comprehensive safety labels in every commercial, effectively making traditional 30-second a

Campaign US reports that the FDA is moving to eliminate the 1997 guidance allowing simplified risk disclosures in broadcast media. This shift would require pharmaceutical brands to include comprehensive safety labels in every commercial, effectively making traditional 30-second a